SCHEMBL12833148

SCHEMBL12833148

Bc1cnc(NC(=O)NCC)cc1-c1nc(C(F)(F)F)c(CNC2CC2)s1

nearest known ligand 0.41

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12833143 0.94
SCHEMBL2130651 0.90 MAPK1 (0.37) MAPK1
SCHEMBL2135225 0.86
SCHEMBL2136636 0.85
SCHEMBL12832828 0.84 MAPK1 (0.37) MAPK1
SCHEMBL2136015 0.84
SCHEMBL12832829 0.83 ABL1 (0.39) MAPK1
SCHEMBL2136693 0.82
SCHEMBL12833147 0.81 FGFR1 (0.43)
SCHEMBL12832827 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011024004-A1 HETEROCYCLIC UREA DERIVATIVES USEFUL FOR TREATMENT OF BACTERIAL INFECTION ASTRAZENECA AB (SE) 2011-03-03 WO disclosed
WO-2009106885-A1 HETEROCYCLIC UREA DERIVATIVES AND METHODS OF USE THEREOF-211 ASTRAZENECA AB (SE) 2009-09-03 WO disclosed